These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35760380)

  • 1. Classification of Omicron BA.1, BA.1.1, and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data.
    Hirotsu Y; Maejima M; Shibusawa M; Natori Y; Nagakubo Y; Hosaka K; Sueki H; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    Int J Infect Dis; 2022 Sep; 122():486-491. PubMed ID: 35760380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
    Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM
    J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerating pandemic response with the emergency Omicron RT-PCR test: A comprehensive solution for COVID-19 diagnosis and tracking.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Chen CS; Tang SH; Perng CL; Chang FY; Wang CH; Hung YJ; Shang HS
    J Med Virol; 2023 Jul; 95(7):e28914. PubMed ID: 37394776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of SARS-CoV-2 Omicron variant using spike gene target failure and genotyping assays, Gauteng, South Africa, 2021.
    Subramoney K; Mtileni N; Bharuthram A; Davis A; Kalenga B; Rikhotso M; Maphahlele M; Giandhari J; Naidoo Y; Pillay S; Ramphal U; Ramphal Y; Tegally H; Wilkinson E; Mohale T; Ismail A; Mashishi B; Mbenenge N; de Oliveira T; Makatini Z; Fielding BC; Treurnicht FK;
    J Med Virol; 2022 Aug; 94(8):3676-3684. PubMed ID: 35441368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a simple genotyping method based on indel mutations to rapidly screen SARS-CoV-2 circulating variants: Delta, Omicron BA.1 and BA.2.
    Ayadi W; Taktak A; Gargouri S; Smaoui F; Chtourou A; Skouri-Gargouri H; Derbel R; Sassi AH; Gargouri A; Hammami A; Karray-Hakim H; Mokdad-Gargouri R; Fki-Berrajah L
    J Virol Methods; 2022 Sep; 307():114570. PubMed ID: 35724698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 Using a High-Resolution Melting-Based Assay: a Pilot Study.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    Microbiol Spectr; 2022 Aug; 10(4):e0136722. PubMed ID: 35861527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineating the Spread and Prevalence of SARS-CoV-2 Omicron Sublineages (BA.1-BA.5) and Deltacron Using Wastewater in the Western Cape, South Africa.
    Johnson R; Mangwana N; Sharma JR; Muller CJF; Malemela K; Mashau F; Dias S; Ramharack P; Kinnear C; Glanzmann B; Viraragavan A; Louw J; Surujlal-Naicker S; Nkambule S; Webster C; Mdhluli M; Gray G; Mathee A; Preiser W; Vorster A; Dalvie S; Street R
    J Infect Dis; 2022 Oct; 226(8):1418-1427. PubMed ID: 36017801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern.
    Yan T; Xu Y; Zheng R; Zeng X; Chen Z; Lin S; Xia Z; Liao Y; Zhang Y; Li Q
    Microbiol Spectr; 2022 Oct; 10(5):e0322222. PubMed ID: 36106882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of novel SARS-CoV-2 rapid antigen tests in the era of omicron outbreak.
    Widyasari K; Kim S
    PLoS One; 2023; 18(8):e0289990. PubMed ID: 37561721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Single-Nucleotide Polymorphism (SNP) Validity to Detect Omicron Variants.
    Partakusuma LG; Budiailmiawan L; Budiman ; Parwati I; Aryati ; Andriyoko B; Markus L; Niswara C; Cinthia Alamanda CN
    Adv Virol; 2023; 2023():6618710. PubMed ID: 37719318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5.
    Shuai H; Chan JF; Hu B; Chai Y; Yoon C; Liu H; Liu Y; Shi J; Zhu T; Hu JC; Hu YF; Hou Y; Huang X; Yuen TT; Wang Y; Zhang J; Xia Y; Chen LL; Cai JP; Zhang AJ; Yuan S; Zhou J; Zhang BZ; Huang JD; Yuen KY; To KK; Chu H
    EBioMedicine; 2023 Sep; 95():104753. PubMed ID: 37579626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides.
    Zhu Y; Hu Y; Liu N; Chong H; He Y
    Antiviral Res; 2022 Dec; 208():105445. PubMed ID: 36265805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021.
    Vauhkonen H; Nguyen PT; Kant R; Plyusnin I; Erdin M; Kurkela S; Liimatainen H; Ikonen N; Blomqvist S; Liitsola K; Lindh E; Helve O; Jarva H; Loginov R; Palva A; Hannunen T; Hannula S; Parry M; Kauppi P; Vaheri A; Sironen T; Lappalainen M; Savolainen-Kopra C; Smura T; Vapalahti O
    Emerg Infect Dis; 2022 Jun; 28(6):1229-1232. PubMed ID: 35378057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the Omicron SARS-CoV-2 Lineage and Its BA.1 Variant with Multiplex RT-qPCR.
    Yolshin ND; Komissarov AB; Varchenko KV; Musaeva TD; Fadeev AV; Lioznov DA
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends.
    Farahat RA; Abdelaal A; Umar TP; El-Sakka AA; Benmelouka AY; Albakri K; Ali I; Al-Ahdal T; Abdelazeem B; Sah R; Rodriguez-Morales AJ
    Infez Med; 2022; 30(4):480-494. PubMed ID: 36482957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2.
    Parums DV
    Med Sci Monit; 2022 Jul; 28():e937676. PubMed ID: 35775166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Identification of SARS-CoV-2 Omicron BA.5 Spike Mutation F486V in Clinical Specimens Using a High-Resolution Melting-Based Assay.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Kinoshita M; Kuriki M; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.
    Xia S; Wang L; Zhu Y; Lu L; Jiang S
    Signal Transduct Target Ther; 2022 Jul; 7(1):241. PubMed ID: 35853878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns.
    Gruell H; Vanshylla K; Korenkov M; Tober-Lau P; Zehner M; Münn F; Janicki H; Augustin M; Schommers P; Sander LE; Kurth F; Kreer C; Klein F
    Cell Host Microbe; 2022 Sep; 30(9):1231-1241.e6. PubMed ID: 35921836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis.
    Relan P; Motaze NV; Kothari K; Askie L; Le Polain O; Van Kerkhove MD; Diaz J; Tirupakuzhi Vijayaraghavan BK
    BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37419502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.